Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Mar, 19 2025
Dec, 15 2025
Sep, 22 2025
Sep, 4 2023